The European cannabis events season is now in full swing, and this month all eyes are turning to Switzerland, one
LINNEA SA (“Linnea,” or “the Company”), a leading pharmaceutical manufacturer with over 40 years of experience, has been granted a narcotics
LAST week Switzerland became the latest in a string of European countries to relax its restrictive access to medical cannabis
Susanne Caspar CEO of Swiss botanical extraction company Linnea SA analyses Europe’s latest CBD deliberations. WE were not surprised by the European
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
